Cargando…
Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles
Triple-negative breast cancer (TNBC) is associated with poor survival as chemotherapy is currently limited to conventional cytotoxic agents. Curcumin has promising anticancer actions against TNBC, but its application is hindered by poor bioavailability and rapid degradation in vivo. In the present s...
Autores principales: | Jung, Kyung-Ho, Lee, Jin Hee, Park, Jin Won, Kim, Da Hae, Moon, Seung-Hwan, Cho, Young Seok, Lee, Kyung-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958779/ https://www.ncbi.nlm.nih.gov/pubmed/29805641 http://dx.doi.org/10.3892/ol.2018.8471 |
Ejemplares similares
-
Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells
por: Kil, Won Ho, et al.
Publicado: (2014) -
PRIMA-1(MET) Does Not Restore Vitamin
D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast
Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023) -
Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Alsrhani, Abdullah, et al.
Publicado: (2023) -
Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468
por: Ashourpour, Maryam, et al.
Publicado: (2021) -
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells
por: Di Sotto, Antonella, et al.
Publicado: (2022)